JamesBaronWetmoreMD

Nephrology • Minneapolis, MN

Associate Professor, Internal Medicine, University Kansas School of Medicine

Join to view full profile

Dr. Wetmore is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wetmore's full profile

Already have an account?

Office
701 Park Ave
Shapiro 5 Nephrology
Minneapolis, MN 55415
Phone+1 612-873-6988

Education & Training

University of California (San Francisco)Fellowship, Nephrology, 2000 - 2005
University of Alabama Medical CenterResidency, Internal Medicine, 1997 - 2000
University of Texas Southwestern Medical SchoolClass of 1997

Certifications & Licensure

CA State Medical License 2000 - Present
MN State Medical License 2013 - 2025
KS State Medical License Active through 2013
AL State Medical License 1998 - 2000
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Association of FGF-23 and Parathyroid Hormone (PTH) in Dialysis Patients Start of enrollment: 2007 Jan 01
Completed
Not Applicable

Publications & Presentations

PubMed

1 citations
Classification of chronic kidney disease in older Australian adults by the CKD-EPI 2009 and 2021 equations: secondary analysis of ASPREE study data.
Elisa K Bongetti, Rory Wolfe, James B Wetmore, Anne M Murray, Robyn L Woods
The Medical Journal of Australia. 2025-02-03
Pain Coping Skills Training for Patients Receiving Hemodialysis: The HOPE Consortium Randomized Clinical Trial.
Laura M Dember, Jesse Y Hsu, Rajnish Mehrotra, Kerri L Cavanaugh, Sahir Kalim
JAMA Internal Medicine. 2025-02-01
Peritoneal Dialysis-Associated Peritonitis Rates in the Outpatient and Hospital Setting Among Incident Dialysis Patients With Medicare, 2009-2018.
Christopher Knapp, Shuling Li, Chuanyu Kou, James B Wetmore, Kirsten L Johansen
Kidney Medicine. 2025-01-01

Lectures

The Vitamin D Debate in CKD and SHPT: How High Should We Aim?
American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/8/2019

Press Mentions

ESKD Treatment Dropped Sharply During Height of COVID-19 PandemicSeptember 28th, 2021
Highlights from the August 2021 IssueAugust 2nd, 2021
Readmission Rates High for HD Patients After CVD HospitalizationMarch 6th, 2018
Join now to see all

Grant Support

Factors Associated With Warfarin Use In Dialysis Patients W/ Atrial FibrillationNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2012